Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 14-16 April 2026
EMA recommends authorisation of first veterinary vaccine using RNA technology
Human medicines European public assessment report (EPAR): Rezurock, belumosudil, Date of authorisation: 24/03/2026, Status: Authorised
Human medicines European public assessment report (EPAR): Livmarli, maralixibat chloride, Date of authorisation: 09/12/2022, Revision: 10, Status: Authorised
Human medicines European public assessment report (EPAR): Atriance, nelarabine, Date of authorisation: 22/08/2007, Revision: 30, Status: Authorised
Human medicines European public assessment report (EPAR): Steqeyma, ustekinumab, Date of authorisation: 22/08/2024, Revision: 9, Status: Authorised
Recommendations on medication errors
Minutes - HMA-EMA joint Network Data Steering Group meeting - 9 March 2026
Q&A clinic on eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) service - June 2026, Online, from 11 June 2026, 15:00 (CEST) to 11 June 2026, 16:00 (CEST)
Q&A clinic on eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) service - July 2026, Online, from 9 July 2026, 15:00 (CEST) to 9 July 2026, 16:00 (CEST)